Qualcomm announced it has three new technology partners who will make components for its standalone virtual reality headsets. The company is now going to work with more partners for its Head Mounted Display Accelerator Program (HAP), including sensor maker Bosch Sensortec, image sensor maker OmniVision, and controller maker Ximmerse, according to Hugo Swart, product manager for VR […]
NYS Entity Status
NYS Filing Date
JULY 18, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2014 - HAP FIVE VENTURE MANAGER LLC
AROUND THE WEB
- Qualcomm finds new tech partners for its standalone VR headset
By Dean Takahashi - Tuesday Jun 27, 2017
- Ric Flair concerns grow as ‘prayers’ asked for
By News.com.au - Monday Aug 14, 2017
There are fears for wrestling icon Ric Flair’s life after his management asked fans to pray for him as he battles “tough medical issues.” CEO of Legacy Talent LLC Melinda Morris Zanoni took to Twitter overnight Sunday to ask for support. It comes after Flair was admitted to a hospital over the weekend for what...
- Five Sites of New York’s L.G.B.T. History
Monday Jun 19, 2017
Jacob Riis Park, a Manhattan church, the Bum Bum Bar and more. In 360 degrees, visit five sites that helped shape New York City’s L.G.B.T. community and its history.
- Kidd Creole of Grandmaster Flash and the Furious Five Is Charged With Murder
By MATTHEW HAAG - Thursday Aug 3, 2017
The police in New York City said that the performer, whose real name is Nathaniel Glover, stabbed a homeless man in Midtown on Monday.
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs
By Bruce V. Bigelow - Tuesday Jul 25, 2017
San Diego’s Effector Therapeutics, a five-year-old cancer drug developer, has raised $38.6 million in new venture capital funding. The Series C financing, led by Pfizer Venture Investments, brings total funding for Effector to about $150 million, CEO Steve Worland said late Monday. The company said it plans to use the new funding to advance testing […]